MSH|^~\&|LAB|RCH|||201912111123||ORU^R01|4127263|D|2.3|||AL|NE
PID|1||RC00007325|RC7134|LABTEST^AIR^UPTEMPO||19740306|M||||||||||RC000949/18|9875474973
OBR|1|36659^LAB|00027792^1112:CU00001R^LAB^111219:CU1^36659|560.0100^UDAS^Urine Drugs of Abuse Screen^^^XBC410-1||201912111122|201912110637|||||||201912110702||||||||||LAB|F||||
OBX|1|ST|560.0200^UAMPH^Urine Amphetamines^^19261-7^19261-7|1|NOT Detected^^N|||N||A^S|F|||201912111123
OBX|2|ST|560.0400^UBENZ^Urine Benzodiazepines^^14316-4^14316-4|1|NOT Detected^^N|||N||A^S|F|||201912111123
OBX|3|ST|560.0600^UCOCA^Urine Cocaine^^19359-9^19359-9|1|DETECTED^^N|||H||A^S|F|||201912111123
OBX|4|ST|560.0700^UMETH^Urine Methadone^^19550-3^19550-3|1|NOT Detected^^N|||N||A^S|F|||201912111123
OBX|5|ST|560.0800^UOPIA^Urine Opiates^^19295-5^19295-5|1|NOT Detected^^N|||N||A^S|F|||201912111123
OBX|6|ST|560.0970^UDASCOM^Urine Drug Screen Comment^^X10083^XXX-0024|1|^^N|||N||A^S|F|||201912111123
NTE|1||The immunoassay method used is a presumptive screen.
NTE|2||A "DETECTED" result does not necessarily indicate an
NTE|3||overdose.  A "NOT detected" result may indicate either
NTE|4||absence of drug or a level below the sensitivity of the
NTE|5||assay.
OBX|7|ST|560.1400^UFENT R^Urine Fentanyl^^59673-4^59673-4|1|DETECTED^^N|||H||A^S|F|||201912111123

MSH|^~\&|LAB|RCH|||201912111123||ORU^R01|4127264|D|2.3|||AL|NE
PID|1||RC00007325|RC7134|LABTEST^AIR^UPTEMPO||19740306|M||||||||||RC000949/18|9875474973
OBR|1|36660^LAB|00027792^1112:CE00001R^LAB^111219:CE1^36660|500.5640^BNP^B type Natriuretic Peptide^^^30934-4||201912111122|201912110637|||||||201912110702||||||||||LAB|F||||
OBX|1|ST|500.5650^BNP R^B Type Natriuretic Peptide^^30934-4^30934-4|1|175^^Y|pg/mL|0-100|H||A^S|F|||201912111123
NTE|1||BNP Interpretive Guidelines:
NTE|2||< 100     pg/mL  Does not support CHF
NTE|3||100 - 250 pg/mL  Borderline zone CHF
NTE|4||250 - 400 pg/mL  Supports CHF
NTE|5||> 400     pg/mL  Strongly supports CHF
NTE|6||Contact designated speciality Pathologist if required.

MSH|^~\&|LAB|RCH|||201912111125||ORU^R01|4127269|D|2.3|||AL|NE
PID|1||RC00007325|RC7134|LABTEST^AIR^UPTEMPO||19740306|M||||||||||RC000949/18|9875474973
OBR|1|36661^LAB|00027792^1112:C00007R^LAB^111219:C7^36661|500.2500^CRE^Creatinine \T\ EGFR^^^45066-8||201912111122|201912110637|||||||201912110702||||||||||LAB|F||||
OBX|1|ST|500.2600^CR^Creatinine Modified Jaffe^^14682-9^14682-9|1|< 27^^Y|umol/L|45-110|L||A^S|F|||201912111125
OBX|2|ST|500.2700^EGFR^Glomerular Filtration Rate Est^^33914-3^33914-3|1|> 120^^Y|mL/min|>60|N||A^S|F|||201912111125
OBR|2|36661^LAB|00027792^1112:C00007R^LAB^111219:C7^36661|500.2900^GLU^Glucose, Random^^14749-6^14749-6||201912111122|201912110637|||||||201912110702||||||||||LAB|F||||
OBX|1|ST|500.2900^GLU^Glucose, Random^^14749-6^14749-6|1|2.1^^Y|mmol/L|3.6-7.8|LL||A^S|F|||201912111125
NTE|1||*CRITICAL VALUE
OBR|3|36661^LAB|00027792^1112:C00007R^LAB^111219:C7^36661|500.5800^CK^Creatine Kinase^^2157-6^2157-6||201912111122|201912110637|||||||201912110702||||||||||LAB|F||||
OBX|1|ST|500.5800^CK^Creatine Kinase^^2157-6^2157-6|1|40000^^Y|U/L|<165|H||A^S|F|||201912111125
OBR|4|36661^LAB|00027792^1112:C00007R^LAB^111219:C7^36661|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7||201912111122|201912110637|||||||201912110702||||||||||LAB|F||||
OBX|1|ST|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7|1|265.0^^Y|mg/L|<7.5|H||A^S|F|||201912111125
NTE|1||This high sensitivity CRP method is sensitive to 0.3 mg/L
NTE|2||and is suitable for coronary artery risk assessment:
NTE|3||                         Less than 1.0 mg/L  low risk;
NTE|4||                         1.0 - 3.0 mg/L  intermediate risk;
NTE|5||                         Greater than 3.0 mg/L  high risk.
NTE|6||Values greater than 7.5 mg/L are significant for active
NTE|7||inflammation or infection and require follow up as
NTE|8||clinically needed. For consultation on specific patient
NTE|9||cases call your site Medical Biochemist. Interpretation
NTE|10||should be based on full history and other risk assessment
NTE|11||factors.
OBR|5|36661^LAB|00027792^1112:C00007R^LAB^111219:C7^36661|530.6700^GENTP^Gentamicin Peak Level^^^3663-2||201912111122|201912110637|||||||201912110702||||||||||LAB|F||||
OBX|1|ST|530.6840^GENTP R^Gentamicin Peak^^3663-2^3663-2|1|4.1^^Y|mg/L|0.0-10.0|N||A^S|F|||201912111125